Cargando…

Understanding CD8(+) T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope

The Wilms' tumor 1 (WT1) antigen is expressed in solid and hematological malignancies, but not healthy tissues, making it a promising target for cancer immunotherapies. Immunodominant WT1 epitopes, the native HLA-A2/WT1(126-134) (RMFPNAPYL) (HLA-A2/RMFPNAPYL epitope (WT1A)) and its modified var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Thi HO, Tan, Amabel CL, Xiang, Sue D, Goubier, Anne, Harland, Kim L, Clemens, E Bridie, Plebanski, Magdalena, Kedzierska, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382434/ https://www.ncbi.nlm.nih.gov/pubmed/28435676 http://dx.doi.org/10.1038/cti.2017.4

Ejemplares similares

Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8(+) T Cell Responses
por: Xiang, Sue D., et al.
Publicado: (2018)

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure
por: Khor, Seik-Soon, et al.
Publicado: (2021)

A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial
por: Tan, Amabel CL, et al.
Publicado: (2015)

Identification of a novel HLA-A(*)02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene
por: YOSHIMURA, MAYUKO, et al.
Publicado: (2014)

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2020)

Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2021)

Identification of HLA‐A*11:01‐restricted Mycobacterium tuberculosis CD8(+) T cell epitopes
por: Liu, Su‐Dong, et al.
Publicado: (2016)

HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
por: Kutszegi, Nóra, et al.
Publicado: (2017)

T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles
por: Hensen, Luca, et al.
Publicado: (2022)

LBA73 The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:01
por: Kvistborg, P., et al.
Publicado: (2020)

Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice
por: El Bissati, Kamal, et al.
Publicado: (2020)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

HLA-A*11:01-restricted CD8(+) T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people
por: Habel, Jennifer R., et al.
Publicado: (2022)

Functional Profile of CD8(+) T-Cells in Response to HLA-A*02:01-Restricted Mutated Epitopes Derived from the Gag Protein of Circulating HIV-1 Strains from Medellín, Colombia
por: Sánchez-Martínez, Alexandra, et al.
Publicado: (2022)

HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children
por: Amstutz, Ursula, et al.
Publicado: (2013)

A TCR mimic monoclonal antibody for the HPV-16 E7-epitope p11-19/HLA-A*02:01 complex
por: Dao, Tao, et al.
Publicado: (2022)

Associations of HLA‐C*01:02 and HLA‐B*46:01 with regorafenib‐induced erythema multiforme in Japanese patients with metastatic colorectal cancer
por: Fujita, Ken‐ichi, et al.
Publicado: (2023)

Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies
por: Matsushita, Maiko, et al.
Publicado: (2016)

Two tagging single‐nucleotide polymorphisms to capture HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype associated with asparaginase hypersensitivity
por: Kutszegi, Nóra, et al.
Publicado: (2020)

CD8(+) T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
por: Hensen, Luca, et al.
Publicado: (2021)

Identification of HLA-A*02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8(+) T Cell Recognition In Vivo
por: Takagi, Akira, et al.
Publicado: (2021)

Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations
por: Furukawa, Hiroshi, et al.
Publicado: (2018)

Challenging immunodominance of influenza-specific CD8(+) T cell responses restricted by the risk-associated HLA-A*68:01 allomorph
por: van de Sandt, C. E., et al.
Publicado: (2019)

Definition and characterization of novel HLA-*A02-restricted CD8(+) T cell epitopes derived from JCV polyomavirus with clinical relevance
por: Mani, Jiju, et al.
Publicado: (2016)

Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8(+) T cells
por: Lopes-Ribeiro, Ágata, et al.
Publicado: (2023)

Suboptimal SARS-CoV-2−specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype
por: Habel, Jennifer R., et al.
Publicado: (2020)

Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
por: Gerstner, Christina, et al.
Publicado: (2016)

Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR
por: Szeto, Christopher, et al.
Publicado: (2021)

The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
por: Szeto, Christopher, et al.
Publicado: (2021)

Characterization of the novel HLA‐DQA1*02:01:14 allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

Characterization of the novel HLA‐DPA1*02:01:21 allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

Loss of an Immunodominant HLA-Α *01:01 Restricted Epitope for CD8+ Cytotoxic T Lymphocytes (CTLs) in the Delta Variant of COVID-19: An Example of Immunologic Escape and Implications for Immunologic Treatment
por: Flomenberg, Neal, et al.
Publicado: (2021)

HLA-A(∗)02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses
por: Nesterenko, Pavlo A., et al.
Publicado: (2021)

Corrigendum: Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
por: Gerstner, Christina, et al.
Publicado: (2017)

Structure and Function of HLA-A*02-Restricted Hantaan Virus Cytotoxic T-Cell Epitope That Mediates Effective Protective Responses in HLA-A2.1/K(b) Transgenic Mice
por: Ma, Ying, et al.
Publicado: (2016)

HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease
por: Hosseini, Ehteramolsadat, et al.
Publicado: (2023)

HLA-DRB1∗16:01 and HLA-DQB1∗05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma
por: Wang, Xu, et al.
Publicado: (2021)

Single Nucleotide Variants as Proxies for HLA-A*31:01 in Native American Populations
por: Fernandes, Vanessa Câmara, et al.
Publicado: (2022)

Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma
por: Wang, Stacie S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l2bfpuqp2cvp9umqcccjbsek82